|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
價值評估 |
盈利(現時/預測)
-1.90/-0.76
|
企業價值
108.96M
|
資產負債 |
每股賬面淨值
2.32
|
現金流量 |
現金流量率
--
|
損益表 |
收益
73.48M
|
每股收益
1.36
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘:2024/06/16 02:52 EDT
同行比較之報價最少15分鐘延遲
業務概覽
|
|||
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions. |